Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 7:57 PM
Ignite Modification Date:
2025-12-24 @ 7:57 PM
NCT ID:
NCT03114904
Brief Summary:
The withdrawal syndrome in benzodiazepines and morphine is common in intensive care, the incidence is estimated at 32.1%.
Cerebrospatized patients are probably more prone to withdrawal because they require high doses of sedation.
Moreover, this syndrome is probably deleterious on the cerebral hemodynamics (high point of the therapeutic management).
Study:
NCT03114904
Study Brief:
Protocol Section:
NCT03114904